Nanovex Biotechnologies provides plain polymeric biodegradable nanoparticles and nanocapsules based on poly(lactide-co-glycolide) (PLGA) acid terminated with a lactide/glycolide ratio of 50/50 and a molecular weight of 32000 Da that can be used as drug delivery carriers by means of the incorporation of hydrophobic molecules in the matrix of our PLGA nanoparticles or hydrophilic molecules that can be entrapped into the hydrophilic pockets of our PLGA nanocapsules.

Our PLGA nanoparticles and nanocapsules are ideal to test the compatibility of these carriers in your system, before including any active pharmaceutical ingredient into the nano-scale drug carriers.

In addition, our customers can use our PLGA nanospheres without the need of the encapsulation process since our carriers possess carboxylic groups in their surface that allows the permanent attachment of their therapeutic molecules by the carbodiimide chemistry (service also provided by Nanovex Biotechnologies).

Notably, our PLGA nanoparticles are manufactured without the use of surfactants, so this formulation offers a better surface for physical adsorption, an easy method for surface functionalization without the addition of any chemicals.

Moreover, Nanovex Biotechnologies offers an encapsulation service to incorporate therapeutic hydrophobic molecules, like cancer drugs, or hydrophilic molecules, like proteins, peptides or enzymes, in our PLGA nanospheres